Renal and hepatic accumulation of cadmium and lead in the expression of CYP4F2 and CYP2E1
- 15 November 2005
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 159 (2), 182-191
- https://doi.org/10.1016/j.toxlet.2005.05.016
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Oxidative Stress, Toxicology, and Pharmacology of CYP2E1Annual Review of Pharmacology and Toxicology, 2004
- Cardiovascular pathophysiology of environmental pollutantsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Eicosanoids in cirrhosis and portal hypertensionProstaglandins & Other Lipid Mediators, 2003
- Potential for early involvement of CYP isoforms in aspects of human cadmium toxicityToxicology Letters, 2002
- Associations between human liver and kidney cadmium content and immunochemically detected CYP4A11 apoproteinBiochemical Pharmacology, 2001
- Toxic Metals and Oxidative Stress Part I: Mechanisms Involved in Me-tal induced Oxidative DamageCurrent Topics in Medicinal Chemistry, 2001
- Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samplesBiochemical Pharmacology, 2001
- Bone Lead and Blood Lead Levels in Relation to Baseline Blood Pressure and the Prospective Development of Hypertension The Normative Aging StudyAmerican Journal of Epidemiology, 2001
- Development of a Comprehensive Panel of Antibodies against the Major Xenobiotic Metabolising Forms of Cytochrome P450 in HumansBiochemical Pharmacology, 1998
- Cytochrome P450 4A and 2E1 expression in human kidney microsomesBiochemical Pharmacology, 1997